Method for palliation of pain in human bone cancer using therapeutic tin-117m compositions
Patent
·
OSTI ID:872063
- Setauket, NY
- Middle Island, NY
- Stony Brook, NY
The invention provides a method for the palliation of bone pain due to cancer by the administration of a unique dosage of a tin-117m (Sn-117m) stannic chelate complex in a pharmaceutically acceptable composition. In addition, the invention provides a method for simultaneous palliation of bone pain and radiotherapy in cancer patients using compositions containing Sn-117m chelates. The invention also provides a method for palliating bone pain in cancer patients using Sn-117m-containing compositions and monitoring patient status by imaging the distribution of the Sn-117m in the patients. Also provided are pharmaceutically acceptable compositions containing Sn-117m chelate complexes for the palliation of bone pain in cancer patients.
- Research Organization:
- ASSOC UNIVERSITIES INC
- DOE Contract Number:
- AC02-76CH00016
- Assignee:
- Brookhaven Science Associates LLC (Upton, NY)
- Patent Number(s):
- US 5853695
- Application Number:
- 08/743,287
- OSTI ID:
- 872063
- Country of Publication:
- United States
- Language:
- English
Biodistribution of Sn-117m(4+)DTPA for palliative therapy of painful osseous metastases.
|
journal | January 1993 |
Similar Records
Method for palliation of pain in human bone cancer using therapeutic tin-117m compositions
Therapeutic tin-117m compositions
Formulation for tin-{sup 117m}/diethylenetriaminepentaacetic acids
Patent
·
Mon Dec 28 23:00:00 EST 1998
·
OSTI ID:321189
Therapeutic tin-117m compositions
Patent
·
Tue Dec 31 23:00:00 EST 2002
·
OSTI ID:875037
Formulation for tin-{sup 117m}/diethylenetriaminepentaacetic acids
Patent
·
Mon Dec 20 23:00:00 EST 1999
·
OSTI ID:20013257
Related Subjects
/424/999/600/
acceptable
addition
administration
bone
bone cancer
bone pain
cancer
cancer patient
chelate
chelates
complex
complexes
composition
compositions
compositions contain
compositions containing
containing
distribution
dosage
due
human
imaging
method
monitoring
pain
palliating
palliation
patient
patients
pharmaceutically
pharmaceutically acceptable
provided
provides
radiotherapy
simultaneous
sn-117m
sn-117m chelate
sn-117m-containing
stannic
status
therapeutic
tin-117m
unique
acceptable
addition
administration
bone
bone cancer
bone pain
cancer
cancer patient
chelate
chelates
complex
complexes
composition
compositions
compositions contain
compositions containing
containing
distribution
dosage
due
human
imaging
method
monitoring
pain
palliating
palliation
patient
patients
pharmaceutically
pharmaceutically acceptable
provided
provides
radiotherapy
simultaneous
sn-117m
sn-117m chelate
sn-117m-containing
stannic
status
therapeutic
tin-117m
unique